자가면역질환 진단 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제품 유형별, 검사 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)
Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Product, By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
상품코드:1750733
리서치사:Grand View Research
발행일:2025년 05월
페이지 정보:영문 129 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
자가면역질환 진단 시장 성장과 동향:
Grand View Research, Inc.의 최신 보고서에 따르면, 세계 자가면역질환 진단 시장 규모는 2025년부터 2030년까지 연평균 6.18%의 CAGR로 확대되어 2030년에는 82억 달러에 달할 것으로 추정됩니다. 정부 기관 및 관련 단체들은 이러한 고가의 의료비를 억제하는 동시에 환자들에게 개선된 진단 및 치료 솔루션을 제공하기 위해 노력하고 있습니다. 그 결과, NIH의 자가면역질환 관련 연구개발 프로그램에 대한 자금 지원이 증가하고 있습니다.
또한, 이러한 질병의 발생을 억제하고 실행 가능한 진단 및 치료 옵션을 개발하는 것을 목표로 하는 정부의 호의적인 이니셔티브의 존재는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.
자가면역진단 시술이 증가함에 따라 보다 빠르고 효과적인 결과를 제공하는 장비와 시설에 대한 요구가 증가하고 있습니다. 늘어나는 시술량에 대응하기 위해 진단 검사실은 빠르게 자동화를 향해 나아가고 있습니다. 실험실 자동화는 빠른 처리 시간으로 업무 부담을 줄이고, 표준화되고 반복 가능한 결과를 생성할 수 있도록 도와줍니다.
The global autoimmune disease diagnostics market size is estimated to reach USD 8.20 billion by 2030, expanding at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.
Moreover, the presence of favorable government initiatives aimed at curbing the incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.
Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.
The localized autoimmune disease diagnostics segment dominated the market and accounted for a revenue share of 64.25% in 2024.
The consumables & assays segment accounted for the largest revenue share of 70.43% in 2024. Every laboratory diagnostic test utilizes test kits, reagents, and antibodies.
In terms of test type, the antinuclear antibody tests dominated the market with a revenue share of 42.62% in 2024. The growth of this segment is attributed to affordability, high sensitivity, and extensive availability.
The hospital segment dominated the market in 2024 with a revenue share of 53.32%. The high share is attributed to the increased adoption of autoimmune disease diagnostic practices in hospitals for various diseases.
The North America autoimmune disease diagnostics market dominated the global industry and accounted for a revenue share of 42.70% in 2024. The Asia Pacific autoimmune disease diagnostics market is anticipated to witness a fastest CAGR from 2024 to 2030.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type segment
1.1.1.2. Product segment
1.1.1.3. Test Type segment
1.1.1.4. End use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR's Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Test Type Snapshot
2.3. Product and End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Presence of research funding programs
3.2.1.2. Presence of favorable government initiatives
3.2.1.3. Growing patient awareness levels
3.2.1.4. Technological innovation in the form of lab automation
3.2.2. Market Restraint Analysis
3.2.2.1. Slow diagnostic result turnaround times and lack of skilled healthcare practitioners
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Type Business Analysis
4.1. Autoimmune Disease Diagnostics Market: Type Movement Analysis
